OpenSAFELY Vaccine Coverage Report
AstraZeneca / Priority Group 4
Data from combined, up to 2021-03-07.
| Vaccinated at 2021-03-07 (%) | Vaccinated at 2021-03-07 (n) | Population | Vaccinated at 2021-02-28 (%) | Vaccinated in past week (%) | ||
|---|---|---|---|---|---|---|
| Overall | - | 53.6% | 2,505,097 | 4,677,344 | 51.2% | 2.4% |
| Sex | Female | 52.8% | 1,328,313 | 2,516,465 | 50.1% | 2.7% |
| Male | 54.5% | 1,176,784 | 2,160,879 | 52.4% | 2.1% | |
| Ethnicity | White - British | 57.6% | 1,470,119 | 2,551,731 | 56.0% | 1.6% |
| White - Irish | 51.0% | 14,280 | 27,993 | 49.8% | 1.2% | |
| White - Any other White background | 40.0% | 58,289 | 145,677 | 37.0% | 3.0% | |
| Mixed - White and Black Caribbean | 34.0% | 4,011 | 11,795 | 29.7% | 4.3% | |
| Mixed - White and Black African | 33.1% | 4,025 | 12,152 | 27.2% | 5.9% | |
| Mixed - White and Asian | 41.9% | 3,185 | 7,609 | 36.8% | 5.1% | |
| Mixed - Any other mixed background | 37.2% | 5,726 | 15,386 | 32.3% | 4.9% | |
| Asian or Asian British - Indian | 44.6% | 54,194 | 121,583 | 39.2% | 5.4% | |
| Asian or Asian British - Pakistani | 36.2% | 35,329 | 97,552 | 28.8% | 7.4% | |
| Asian or Asian British - Bangladeshi | 42.0% | 20,769 | 49,469 | 29.1% | 12.8% | |
| Asian or Asian British - Any other Asian background | 40.4% | 25,956 | 64,267 | 34.7% | 5.6% | |
| Black or Black British - Caribbean | 31.2% | 13,342 | 42,756 | 27.0% | 4.2% | |
| Black or Black British - African | 30.8% | 31,885 | 103,684 | 24.3% | 6.4% | |
| Black or Black British - Any other Black background | 29.8% | 5,614 | 18,809 | 24.9% | 5.0% | |
| Other ethnic groups - Chinese | 42.2% | 5,880 | 13,923 | 37.6% | 4.7% | |
| Other ethnic groups - Any other ethnic group | 36.7% | 14,364 | 39,109 | 31.1% | 5.6% | |
| Patients with any other ethnicity code | 54.7% | 338,905 | 619,885 | 52.6% | 2.1% | |
| Ethnicity not stated | 54.1% | 15,435 | 28,539 | 51.5% | 2.6% | |
| Ethnicity not recorded | 54.4% | 383,670 | 705,327 | 52.3% | 2.1% | |
| Ethnicity (broad categories) | White | 56.6% | 1,542,695 | 2,725,415 | 55.0% | 1.7% |
| Mixed | 36.1% | 16,975 | 46,963 | 31.1% | 5.1% | |
| South Asian | 40.9% | 136,269 | 332,892 | 33.8% | 7.2% | |
| Black | 30.8% | 50,855 | 165,249 | 25.1% | 5.7% | |
| Other | 38.2% | 20,258 | 53,032 | 32.8% | 5.4% | |
| Unknown | 54.5% | 738,031 | 1,353,758 | 52.4% | 2.1% | |
| Index of Multiple Deprivation | 1 (most deprived) | 49.9% | 846,517 | 1,697,661 | 46.6% | 3.3% |
| 2 | 51.3% | 384,545 | 749,511 | 48.3% | 3.0% | |
| 3 | 55.3% | 417,879 | 755,258 | 53.4% | 1.9% | |
| 4 | 57.4% | 420,133 | 731,542 | 56.0% | 1.4% | |
| 5 (least deprived) | 59.0% | 413,217 | 700,854 | 57.9% | 1.1% | |
| Unknown | 53.6% | 22,785 | 42,497 | 51.0% | 2.6% | |
| Clinical Risk Groups | Patients in Any Clinical Risk Group | 52.0% | 1,560,153 | 2,999,115 | 48.7% | 3.3% |
| Patients with Immunosuppression | 52.7% | 227,304 | 431,417 | 51.0% | 1.7% | |
| Patients with CKD | 56.6% | 231,112 | 408,618 | 55.3% | 1.3% | |
| Patients who have Chronic Respiratory Disease | 56.7% | 332,759 | 587,062 | 55.4% | 1.3% | |
| Patients with Diabetes | 47.3% | 644,420 | 1,363,726 | 41.2% | 6.0% | |
| Patients with Chronic Liver disease | 52.5% | 110,684 | 210,861 | 49.3% | 3.2% | |
| Patients with CNS Disease (including Stroke/TIA) | 56.2% | 231,168 | 411,411 | 54.0% | 2.2% | |
| Patients with Chronic heart disease | 57.1% | 532,525 | 932,001 | 55.6% | 1.5% | |
| Patients with Asplenia or Dysfunction of the Spleen | 50.1% | 41,356 | 82,593 | 48.7% | 1.4% | |
| Patients with Wider Learning Disability | 50.6% | 28,413 | 56,203 | 46.2% | 4.3% | |
| Patients with Severe Mental Health | 47.9% | 37,331 | 77,938 | 42.8% | 5.1% | |
| Other Groups | Patients who are shielding (High Risk from COVID-19) | 47.6% | 1,081,479 | 2,273,628 | 43.1% | 4.5% |
| Patients with Morbid Obesity | 49.5% | 164,927 | 332,871 | 43.9% | 5.7% | |
| Patients who are pregnant | 18.1% | 5,250 | 28,973 | 12.1% | 6.0% |